A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

NCT05345236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: Aflibercept

Sponsor

Qilu Pharmaceutical Co., Ltd.